Latest Commercial Operations News

Jade Gas Holdings has achieved continuous gas flow from two production wells and secured its first LNG sales agreement with Mongolia’s largest natural gas importer, UB Metan LLC. The company also raised $5 million to support its commercial operations.

Bubs Australia reported a 30% increase in net revenue to $25.6 million for Q1 FY26, driven by robust US sales and a return to profitability with positive EBITDA. Despite inventory challenges in other regions, the company maintains a solid cash position and anticipates FDA approval by year-end.

Frontier Energy secures 88.06 MW capacity credits for its Waroona Project Stage One, guaranteeing approximately $32 million in annual fixed revenue and outlining a multi-stage expansion aligned with Western Australia's energy transition.

Pure Resources has completed the acquisition of the Garnet Hills mining lease and confirmed high-grade garnet products through metallurgical testing, positioning itself for feasibility studies and U.S. partnerships.

IperionX has boosted titanium powder production capacity by 60% and secured US$75 million in Department of War funding to scale up to 1,400 tonnes per annum by 2027, aiming to become the largest and lowest-cost US titanium producer.

Novonix Limited has achieved its first mass production of industrial-grade synthetic graphite and secured significant funding, advancing its position in North America's battery materials supply chain.

Elixir Energy is set to resume production testing at its Diona-1 well this quarter and prepare for the high-impact Lorelle-3 appraisal well drilling in January 2026, aiming to unlock significant gas resources in Queensland’s Taroom Trough.

Pursuit Minerals progresses its Rio Grande Sur lithium project with a refined commercial plan and feasibility study, while expanding into gold through the Sascha Marcelina acquisition. A recent $4 million placement strengthens its financial position for growth.

Murray Cod Australia Ltd reports a robust start to FY26 with a 45% increase in sales and a $17 million capital raise, driven by expanded production and market access including new Halal certification.

Artrya Limited has secured FDA clearance for its Salix Coronary Plaque module and raised $80 million to fuel its U.S. commercial expansion, marking a pivotal step in its transition from development to revenue generation.

Vitrafy Life Sciences has delivered its first production unit of the next-generation cryopreservation device, advanced its US commercial footprint, and maintained a strong financial position heading into FY2026.

Botanix Pharmaceuticals reports a strong start to FY26 with a 50% surge in Sofdra prescriptions and a 65% rise in net revenue, underpinned by a larger sales team and operational efficiencies.